Christopher D Byrne

National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom, United Kingdom

Disclosure information not submitted.

Presentation(s):

• Risk of Hepatic Events Associated with Use of SGLT-2 Inhibitors Versus GLP-1RA, and Thiazolidinedione Among Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes

  Wednesday, August 28, 2024
  2:15 PM – 2:30 PM CEST